Sign in

NCT07536503Recruiting

Effects of Sleep Quality on Functional and Cognitive Outcomes in Multiple Sclerosis

Effects of Sleep Quality on Cognitive Flexibility, Physical Activity, Body Awareness, and Reaction Time in Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 2 Jun 2026

Brief summary (registry, in English)

The goal of this observational study is to investigate the effects of sleep quality on cognitive flexibility, physical activity level, body awareness, and reaction time in individuals with Multiple Sclerosis. The main question it aims to answer is: Does sleep quality influence cognitive flexibility, physical activity level, body awareness, and reaction time in individuals with Multiple Sclerosis? Researchers will compare individuals with good and poor sleep quality to determine whether differences in sleep quality result in variations in cognitive and physical performance outcomes. Participants will complete standardized assessments of sleep quality, cognitive flexibility, physical activity, and body awareness, and will perform a computer-based reaction time test. In addition, participants will wear a wearable activity tracker for 7 days to objectively measure physical activity levels.

Status (registry)
Recruiting
Study type
Observational
Enrollment
80 (estimated)
First submitted
11 Apr 2026
Start date
1 May 2026
Primary completion date
1 Jul 2026
Lead sponsor
Büşra Seçkinoğulları Korkusuz
NCT number
NCT07536503

What you commit to

  • Study type: Observational
  • Planned participants: 80
  • From 1 May 2026 to the primary completion date, 1 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of sleep medication or central nervous system-affecting drugs

Other illness

  • Presence of other neurological, psychiatric, or systemic diseases
  • History of surgery within the last 6 months

Other

  • Severe visual, auditory, or balance impairments
  • Severe orthopedic deformity or pain

Who the study is looking for

  • Age between 18 and 65 years
  • Diagnosis of Multiple Sclerosis
  • Montreal Cognitive Assessment (MoCA) score ≥24
  • Expanded Disability Status Scale (EDSS) score between 0 and 6.5
  • No relapse within the last 3 months
  • Voluntary participation with written informed consent

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Baskent University Ankara Hospital
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.